Form 4: Autoliv Director Laurie Brlas Reports Stock Transactions
SEC Form 4
Director Laurie Brlas reports vesting of restricted stock units and grant of new units related to director service.
Summary
- Laurie Brlas, a director of Autoliv Inc. (ALV), reported transactions involving the company's stock.
- On May 8, 2025, 1,261 restricted stock units (RSUs) vested, converting into common stock.
- Also on May 8, 2025, Brlas was granted 1,706 RSUs as part of the 2025-2026 annual retainer for non-employee director service.
- Following these transactions, Brlas directly owns 8,225 shares of Autoliv common stock and 1,706 RSUs.
Sentiment
Score: 5
Explanation: This is a routine filing indicating standard compensation practices, neither particularly positive nor negative.
Positives
- The grant of RSUs to a director aligns their interests with those of the shareholders.
Future Outlook
The newly granted RSUs will vest on the earlier of Autoliv's 2026 annual stockholder meeting or May 8, 2026.
Industry Context
This filing is a routine disclosure of stock transactions by a company director, which is common practice for publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard director compensation.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of RSU grant that vested on 05/08/2025 |
| 05/08/2025 | Date of RSU vesting and new RSU grant |
| 05/08/2026 | One-year anniversary of the RSU grant, potential vesting date |
| ALV's 2026 annual stockholder meeting | Potential vesting date for the new RSU grant |
Keywords
Autoliv, Director, Stock, RSU, ALV, Brlas, Vesting, Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.